Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
29 July 2022 |
Main ID: |
NCT02981979 |
Date of registration:
|
22/11/2016 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Takayasu Arteritis Clinical Trial in China
TACTIC |
Scientific title:
|
Comparison of the Efficacy and Safety of Leflunomide Versus Placebo Combine With the Basic Prednisone Therapy in Patients With Active Phase of Takayasu's Arteritis: a Randomized Controlled Double-blinded Trial |
Date of first enrolment:
|
December 2016 |
Target sample size:
|
116 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT02981979 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Bingjie Wu, Doctor |
Address:
|
|
Telephone:
|
+86 135-6422-3680 |
Email:
|
wu.bingjie@zs-hospital.sh.cn |
Affiliation:
|
|
|
Name:
|
Lindi Jiang, Doctor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Shanghai Zhongshan Hospital |
| |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|